IBRX:NASDAQ
Immunitybio Inc
၆.၅၇ US$
arrow_downward
-၁.၉၄%(-၀.၁၃) 1D
၆.၅၀ US$
arrow_downward
-၁.၀၇% (-၀.၀၇၀)bedtimeAfter hours
Closed: နို ၁၉, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IBRX...
Open
၆.၇၂ US$
High
၆.၈၃ US$
Low
၆.၄၁ US$
Mkt. cap
၆၉၈.၉၃ ဋေ
Avg. vol.
၁.၄၄ ကုဋေ
Volume
၁.၁၁ ကုဋေ
52-wk high
၁၂.၄၃ US$
52-wk low
၁.၉၅ US$
EPS
-၁.၀၇ US$
Beta
၀.၁၇
Shares outstanding
၁၀၆.၃၈ ဋေ
No. of employees
၆၈၈
Open
၆.၇၂ US$
High
၆.၈၃ US$
Low
၆.၄၁ US$
Mkt. cap
၆၉၈.၉၃ ဋေ
Avg. vol.
၁.၄၄ ကုဋေ
Volume
၁.၁၁ ကုဋေ
52-wk high
၁၂.၄၃ US$
52-wk low
၁.၉၅ US$
EPS
-၁.၀၇ US$
Beta
၀.၁၇
Shares outstanding
၁၀၆.၃၈ ဋေ
No. of employees
၆၈၈
News stories
From web sources and news partners
citybiz
·
ပြီးခဲ့သည့် ၉ နာရီ
ImmunityBio Ranks No. 2 on 2026 Deloitte Technology Fast 500 With Over 47,000% Revenue Growth
ImmunityBio
·
ပြီးခဲ့သည့် ၁၅ နာရီ
ImmunityBio Named No. 2 Fastest-Growing Technology Company in North America on the 2026 Deloitte Technology Fast 500
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
ImmunityBio (IBRX) Could Be 53% Undervalued As Anktiva Trial Results Lift FDA Hopes
About Immunitybio Inc